Group 1 - The core viewpoint of the report indicates that Cheung Kong's basic profit for the fiscal year 2025 is expected to grow by 7% year-on-year, exceeding both Morgan Stanley's and market consensus forecasts by 4% and 2% respectively [1] - The dividend payout ratio is projected to increase by 5% year-on-year, reflecting positive financial performance [1] - The outlook suggests that excluding sale proceeds, the group is expected to see steady profit growth due to improvements across all core businesses [1] Group 2 - Morgan Stanley anticipates additional earnings from the sale of the UK Power Networks (UKPN) and increased contributions from Cenovus Energy due to rising oil prices, with a potential 35% upside in earnings if WTI remains at $100 per barrel throughout the year [1] - This positive outlook provides upward potential for earnings per share and dividend payout ratio for the fiscal year 2026 [1] - The report maintains an "Overweight" rating, highlighting the attractiveness of Cheung Kong's capital recycling strategy based on improvements in core business [1]

Group 1 - MGM China Holdings Limited (02282) announced a final dividend of HKD 0.353 per share to be distributed on June 3, 2026 [2] - The stock price of MGM China is currently at HKD 11.33, reflecting a decrease of 0.68 or 5.66% [1] - The stock has shown fluctuations with a range between HKD 11.08 and HKD 12.94 over the recent trading period [1] Group 2 - The trading volume for MGM China has reached up to 43,000 shares during the day [1] - The stock has experienced a positive trend in the past month, with increases of 7.74%, 5.16%, and 2.58% noted [1] - The company is actively engaging in shareholder returns through dividend distributions [2]

Group 1 - The core viewpoint of the article highlights the financial performance of MGM China, reporting a revenue increase and profit growth for the fiscal year ending December 31, 2025 [2][3] Group 2 - MGM China's total gaming revenue reached HKD 30.472 billion, reflecting an increase of 11.69% year-on-year [2] - The profit attributable to shareholders was HKD 5.075 billion, marking a year-on-year increase of 10.24% [2] - Basic earnings per share were reported at HKD 1.335, with a proposed final dividend of HKD 0.353 per share [2] Group 3 - The overall gaming market share reached a historical high of 16.1%, up from 15.8% the previous year [3] - The total win amount from main gaming tables increased by 10.2% to HKD 31.51 billion, driven by increased betting amounts at MGM Macau and MGM Cotai [3] - The total win amount from VIP gaming tables rose by 19.5% to HKD 4.8374 billion, primarily due to an increase in VIP win rates [3] - The total win amount from slot machines increased by 3.3% to HKD 2.2963 billion, supported by higher betting amounts despite a decrease in win rates [3]

Group 1 - The core viewpoint of the news is that MGM China reported a significant increase in annual profits and operational metrics for the year ending December 31, 2025, indicating strong performance in the gaming sector [1] Group 2 - MGM China's annual profit attributable to shareholders reached HKD 5.075 billion, representing a year-on-year increase of 10.24% [1] - Adjusted EBITDA hit a record high of HKD 10 billion, up 10.4% year-on-year [1] - Operating revenue increased to HKD 34.7875 billion, reflecting a year-on-year growth of 10.8% [1] - The overall gaming market share reached a historical high of 16.1%, compared to 15.8% the previous year [1] - The company proposed a final dividend of HKD 0.353 per share [1]

Group 1 - The FDA has granted orphan drug designation (ODD) to ABSK061, a significant incentive policy aimed at supporting the development and evaluation of innovative therapies for rare diseases [1][3] - ABSK061 is a highly active and selective small molecule FGFR2/3 inhibitor developed by HeYue Pharmaceutical, showing strong target inhibition activity and promising safety characteristics in preclinical studies [1][2] - The drug is currently undergoing a Phase II clinical trial for children aged 3-12 with achondroplasia (ACH), with the first patient dosed in December 2025 and preliminary data expected in the second half of 2026 [1][2] Group 2 - Following the ODD designation, HeYue Pharmaceutical aims to accelerate the global clinical development and registration process for ABSK061, focusing on providing safe and effective innovative treatment options for ACH patients worldwide [2] - ABSK061 is positioned as a next-generation FGFR inhibitor, potentially offering a wider therapeutic window and improved clinical efficacy by reducing inhibition of FGFR1 while maintaining high activity against FGFR2/3 [2]

Group 1 - The Hang Seng Index opened down by 0.64% [1] - The Hang Seng Tech Index fell by 0.97% [1] - Companies such as NetEase, Xiaomi Group, and JD Group experienced declines of over 2% [1] Group 2 - Li Ning saw an increase of nearly 8% [1] - Contemporary Amperex Technology Co., Ltd. (CATL) rose by over 3% [1]

Core Viewpoint - The company, AAC Technologies (瑞声科技), reported a revenue of RMB 31.82 billion for the fiscal year ending December 31, 2025, marking a 16.4% year-on-year increase, with a net profit attributable to shareholders of RMB 2.51 billion, up 39.8% year-on-year, indicating strong growth driven by advancements in AI and consumer electronics [2]. Group 1: Financial Performance - The company achieved a record revenue of RMB 31.82 billion for the fiscal year, reflecting a 16.4% increase compared to the previous year [2]. - Net profit attributable to shareholders reached RMB 2.51 billion, representing a 39.8% year-on-year growth [2]. - Basic earnings per share were reported at RMB 2.18, with a proposed final dividend of HKD 0.35 per share [2]. Group 2: Business Development and Innovation - The company is transitioning from a hardware provider to a leader in AI perception and interaction systems, leveraging core technologies in acoustics, optics, and electromagnetic fields [2][5]. - The company has solidified its leadership in the acoustic and electromagnetic transmission sectors, with significant advancements in heat dissipation technology through automated production lines [3]. - The optical business is expanding its market share, with increasing adoption of the company's products in high-end camera modules [3]. Group 3: Emerging Markets and Future Prospects - The company is enhancing R&D efficiency and capitalizing on opportunities in emerging markets, particularly in non-mobile AI hardware [4]. - The XR market is accelerating, with the company establishing a leadership position in AR optical design through strategic acquisitions [4]. - The company is focusing on the robotics sector, applying its micro-motor technology to develop advanced robotic joints, indicating a commitment to future growth in this area [5].

Group 1 - The core viewpoint of the news is that 瑞声科技 has achieved record revenue and profit growth for the fiscal year ending December 31, 2025, driven by strong performance in its core businesses and rapid growth in emerging sectors [1] - The company's revenue reached RMB 31.82 billion, representing a year-on-year increase of 16.4% [1] - The profit attributable to shareholders was RMB 2.512 billion, an increase of 39.8% compared to the previous year [1] - Basic earnings per share were reported at RMB 2.18, and the company proposed a final dividend of HKD 0.35 per share, up 45.8% from HKD 0.24 in the same period last year [1] Group 2 - 瑞声科技's stock price increased by over 3%, reaching HKD 34.44, with a trading volume of HKD 1.25 billion [2] - The stock showed a percentage change of -2.18% for the day, with fluctuations observed in the intraday trading [2]

Group 1 - The company Everbright Environment (00257) announced that it will distribute a final dividend of HKD 0.12 per share on July 2, 2026 [1]

Group 1: Company Actions - Cryptocurrency exchange Crypto.com is reducing its workforce by 12% to integrate artificial intelligence into its operations, reflecting a broader trend in the corporate sector [1][2] - CEO Kris Marszalek emphasized that companies must pivot to AI quickly or risk failure, stating that those who combine AI tools with top performers will achieve unprecedented scale and precision [3] - This is not the first workforce reduction for Crypto.com, as the company previously laid off 20% of its global workforce earlier in 2023 due to the collapse of FTX and a focus on prudent financial management [3] Group 2: Industry Trends - The corporate sector is experiencing significant layoffs, with over 39,000 employees laid off by 66 tech companies in 2023, driven by the rapid integration of artificial intelligence [4] - Major companies like Block, Oracle, Amazon, and Meta have also implemented substantial layoffs, often linked to AI-driven cost-cutting measures [6] - HSBC Holdings Plc is considering up to 20,000 job cuts in the coming years as part of an AI-led overhaul, indicating a trend towards workforce reductions across various industries [7]